Literature DB >> 35624357

Revisiting Genetic Testing for Patients with Negative Results: IPEX and FOXP3.

Sarah K Baxter1,2, Suleyman Gulsuner3, David Hagin4, Troy R Torgerson5, Tom Walsh3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35624357     DOI： 10.1007/s10875-022-01292-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.542


× No keyword cloud information.
  4 in total

1.  Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.

Authors:  Jeffrey A SoRelle; Drew M Thodeson; Susan Arnold; Garrett Gotway; Jason Y Park
Journal:  JAMA Pediatr       Date:  2019-01-07       Impact factor: 16.193

2.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

3.  Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene.

Authors:  Troy R Torgerson; Avriel Linane; Nicolette Moes; Stephanie Anover; Véronique Mateo; Frédéric Rieux-Laucat; Olivier Hermine; Shashi Vijay; Eleonora Gambineri; Nadine Cerf-Bensussan; Alain Fischer; Hans D Ochs; Olivier Goulet; Frank M Ruemmele
Journal:  Gastroenterology       Date:  2007-02-23       Impact factor: 22.682

4.  Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome.

Authors:  Eleonora Gambineri; Sara Ciullini Mannurita; David Hagin; Marina Vignoli; Stephanie Anover-Sombke; Stacey DeBoer; Gesmar R S Segundo; Eric J Allenspach; Claudio Favre; Hans D Ochs; Troy R Torgerson
Journal:  Front Immunol       Date:  2018-11-01       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.